IN8BIO INC. - COMMON

0.2962

27-November-24 16:45:00

15 minutes delayed

Stocks

-0.0138

-4.45%

Today's range

0.2900 - 0.3210

ISIN

N/A

Source

NASDAQ

IN8bio to Present at Scientific Conferences in November: PEGS Europe, SITC and SNO

04 Nov 2021 08:00:03 By Nasdaq GlobeNewswire
IN8bio to Present at BioFuture 2021 and Advanced Therapies Congress & Expo 2021

04 Oct 2021 16:15:00 By Nasdaq GlobeNewswire
IN8bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update

10 Sep 2021 16:15:00 By Nasdaq GlobeNewswire
IN8bio to Present at the NewYorkBIO Virtual Breakfast Series and H.C. Wainwright 23rd Annual Global Investment Conference

30 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant

11 Aug 2021 08:00:01 By Nasdaq GlobeNewswire
IN8bio Appoints Emily Fairbairn and Luba Greenwood to Board of Directors

04 Aug 2021 08:00:01 By Nasdaq GlobeNewswire
IN8bio Announces Pricing of Initial Public Offering

30 Jul 2021 07:00:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.